武汉市公立医院药品价格水平实证研究  

Empirical Research on the Medicine Price Level in Wuhan

作　　者：夏冕[1] 赵文静[2] 吕晖[1] 罗五金[1] 

机构地区：[1]华中科技大学同济医学院医药卫生管理学院,湖北武汉430030 [2]兰州大学公共卫生学院,甘肃兰州730000

出　　处：《中国医院管理》2010年第12期66-68,共3页Chinese Hospital Management

摘　　要：目的了解武汉市公立医院的药品相对价格水平,揭示药品市场现存的问题。方法选择全国市场销售排名前100位的药品全部纳入研究样本,收集武汉市12家公立医院和14家零售药房的药品价格数据,对定量资料进行统计分析,对公立医院间及其与零售药房间的药品价格进行差异性比较。结果公立医院的药品均价高于零售药房同商品名药品的均价;公立医院间同商品名的药品均价差异不显著,但同通用名的药品价格差异有较大的波动性。结论与建议进一步建立健全药品监管制度,加快削弱公立医院的垄断地位,严格药品招标采购管理,建立健全国家基本药物制度。Objective To understand the relative medicine price level in public hospitals in Wuhan and reveal the existing problems in the pharmaceutical market.Methods Selecting the medicines that rank top 100 in the national market as the research samples.The data of medicine price was collected from a total of 12 public hospitals and 14 retail pharmacies in Wuhan.The statistical analysis on the quantitative data was conducted and the medicines prices were compared between the public hospitals and retail pharmacies,and among public hospitals.Results The average medicine prices in the public hospitals were higher than those with the same brand name in the retail pharmacies.The differences of average prices of medicines with same brand name among the public hospitals were not significant,while those with same generic name only were of bigger volatility.Conclusions and Suggestions The drug regulatory system should be further established and improved;the weakening of the monopoly position of public hospitals should be sped up;pharmaceutical bidding management be strict and the national essential drugs system be established and improved.

关 键 词：公立医院 药品 价格 

分 类 号：R197.32[医药卫生—卫生事业管理]